Evidence map›Paper›PMID 34094374›Full record

ArticleChemical science2020

2'-

Maximilian Himmelstoß, Kevin Erharter, Eva Renard, Eric Ennifar, Christoph Kreutz, Ronald Micura

Abstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. 2'-Frontiers in molecular biosciences · 2024
    Article
  2. Heterocyclic-Based Analogues against Sarcine-Ricin Loop RNA fromMedicinal chemistry (Shariqah (United Arab Emirates)) · 2024
    Article
  3. Advances in RNA Labeling with Trifluoromethyl Groups.Chemistry (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. 4'-SCFAngewandte Chemie (International ed. in English) · 2022
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maximilian HimmelstoßUniversity of Innsbruck, Institute of Organic Chemistry, Center for Molecular Biosciences (CMBI) Innrain 80-82 6020 Innsbruck Austria ronald.micura@uibk.ac.at christoph.kreutz@uibk.ac.at.
Kevin ErharterUniversity of Innsbruck, Institute of Organic Chemistry, Center for Molecular Biosciences (CMBI) Innrain 80-82 6020 Innsbruck Austria ronald.micura@uibk.ac.at christoph.kreutz@uibk.ac.at.
Eva RenardUniversité de Strasbourg, Architecture et Réactivité de l'ARN-CNRS UPR 9002, Institut de Biologie Moléculaire et Cellulaire 67000 Strasbourg France e.ennifar@ibmc-cnrs.unistra.fr.
Eric EnnifarUniversité de Strasbourg, Architecture et Réactivité de l'ARN-CNRS UPR 9002, Institut de Biologie Moléculaire et Cellulaire 67000 Strasbourg France e.ennifar@ibmc-cnrs.unistra.fr.
Christoph KreutzUniversity of Innsbruck, Institute of Organic Chemistry, Center for Molecular Biosciences (CMBI) Innrain 80-82 6020 Innsbruck Austria ronald.micura@uibk.ac.at christoph.kreutz@uibk.ac.at.ORCID https://orcid.org/0000-0002-7018-9326
Ronald MicuraUniversity of Innsbruck, Institute of Organic Chemistry, Center for Molecular Biosciences (CMBI) Innrain 80-82 6020 Innsbruck Austria ronald.micura@uibk.ac.at christoph.kreutz@uibk.ac.at.ORCID https://orcid.org/0000-0003-2661-6105

Funding

Austrian Science Fund FWF P 27947Austrian Science Fund FWF P 31691Austrian Science Fund FWF P 32773
6 · The paper itself

Abstract

New RNA modifications are needed to advance our toolbox for targeted manipulation of RNA. In particular, the development of high-performance reporter groups facilitating spectroscopic analysis of RNA structure and dynamics, and of RNA-ligand interactions has attracted considerable interest. To this end, fluorine labeling in conjunction with

Identifiers

PMID34094374
PMCPMC8162808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.